These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 18989222

  • 1. Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine.
    Basson AE, Ntsala M, Martinson N, Tlale E, Corrigan GE, Shao X, Gray G, McIntyre J, Puren A, Morris L.
    J Acquir Immune Defic Syndr; 2008 Dec 15; 49(5):538-43. PubMed ID: 18989222
    [Abstract] [Full Text] [Related]

  • 2. Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment.
    Lehman DA, Wamalwa DC, McCoy CO, Matsen FA, Langat A, Chohan BH, Benki-Nugent S, Custers-Allen R, Bushman FD, John-Stewart GC, Overbaugh J.
    J Acquir Immune Defic Syndr; 2012 Jul 01; 60(3):225-33. PubMed ID: 22395670
    [Abstract] [Full Text] [Related]

  • 3. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
    Persaud D, Bedri A, Ziemniak C, Moorthy A, Gudetta B, Abashawl A, Mengistu Y, Omer SB, Isehak A, Kumbi S, Adamu R, Lulseged S, Ashworth R, Hassen E, Ruff A, Ethiopian Swen Study Team.
    AIDS Res Hum Retroviruses; 2011 Aug 01; 27(8):823-9. PubMed ID: 21241214
    [Abstract] [Full Text] [Related]

  • 4. Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
    Eshleman SH, Guay LA, Mwatha A, Cunningham SP, Brown ER, Musoke P, Mmiro F, Jackson JB.
    AIDS Res Hum Retroviruses; 2004 Jun 01; 20(6):595-9. PubMed ID: 15242535
    [Abstract] [Full Text] [Related]

  • 5. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
    Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Glenn Fowler M, Mofenson LM, Mmiro F, Jackson JB.
    AIDS; 2001 Oct 19; 15(15):1951-7. PubMed ID: 11600822
    [Abstract] [Full Text] [Related]

  • 6. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.
    Martinson NA, Morris L, Johnson J, Gray GE, Pillay V, Ledwaba J, Dhlamini P, Cohen S, Puren A, Steyn J, Heneine W, McIntyre JA.
    AIDS; 2009 Apr 27; 23(7):809-16. PubMed ID: 19287298
    [Abstract] [Full Text] [Related]

  • 7. Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine.
    Micek MA, Blanco AJ, Carlsson J, Beck IA, Dross S, Matunha L, Seidel K, Montoya P, Gantt S, Matediana E, Jamisse L, Gloyd S, Frenkel LM.
    J Infect Dis; 2012 Jun 15; 205(12):1811-5. PubMed ID: 22492850
    [Abstract] [Full Text] [Related]

  • 8. Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.
    Hudelson SE, McConnell MS, Bagenda D, Piwowar-Manning E, Parsons TL, Nolan ML, Bakaki PM, Thigpen MC, Mubiru M, Fowler MG, Eshleman SH.
    AIDS; 2010 Feb 20; 24(4):557-61. PubMed ID: 20057308
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
    McIntyre JA, Hopley M, Moodley D, Eklund M, Gray GE, Hall DB, Robinson P, Mayers D, Martinson NA.
    PLoS Med; 2009 Oct 20; 6(10):e1000172. PubMed ID: 19859531
    [Abstract] [Full Text] [Related]

  • 10. Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay.
    Wagner TA, Kress CM, Beck I, Techapornroong M, Wittayapraparat P, Tansuphasawasdikul S, Jourdain G, Ngo-Giang-Huong N, Lallemant M, Frenkel LM.
    J Clin Microbiol; 2010 May 20; 48(5):1555-61. PubMed ID: 20181911
    [Abstract] [Full Text] [Related]

  • 11. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
    Kurle SN, Gangakhedkar RR, Sen S, Hayatnagarkar SS, Tripathy SP, Paranjape RS.
    AIDS Res Hum Retroviruses; 2007 May 20; 23(5):682-5. PubMed ID: 17530993
    [Abstract] [Full Text] [Related]

  • 12. Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.
    Permar SR, Salazar MG, Gao F, Cai F, Learn GH, Kalilani L, Hahn BH, Shaw GM, Salazar-Gonzalez JF.
    Retrovirology; 2013 Aug 14; 10():88. PubMed ID: 23941304
    [Abstract] [Full Text] [Related]

  • 13. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R, Paredes R, Parboosing R, Moodley P, Singh L, Naidoo A, Gordon M.
    J Med Virol; 2015 Oct 14; 87(10):1662-7. PubMed ID: 25940687
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission.
    Flys TS, McConnell MS, Matovu F, Church JD, Bagenda D, Khaki L, Bakaki P, Thigpen MC, Eure C, Fowler MG, Eshleman SH.
    J Infect Dis; 2008 Aug 15; 198(4):465-9. PubMed ID: 18582198
    [Abstract] [Full Text] [Related]

  • 17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.
    Clin Infect Dis; 2008 Feb 15; 46(4):611-21. PubMed ID: 18197758
    [Abstract] [Full Text] [Related]

  • 18. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
    Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, Wang Q.
    Int J STD AIDS; 2009 Apr 15; 20(4):249-54. PubMed ID: 19304969
    [Abstract] [Full Text] [Related]

  • 19. Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
    Kuhn L, Sinkala M, Kankasa MP, Kasonde P, Thea DM, Aldrovandi GM.
    J Acquir Immune Defic Syndr; 2006 Jun 15; 42(2):260-2. PubMed ID: 16760802
    [No Abstract] [Full Text] [Related]

  • 20. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
    Jones D, Parkin N, Hudelson SE, Guay LA, Musoke P, Mmiro F, Jackson JB, Eshleman SH.
    AIDS Res Hum Retroviruses; 2005 Apr 15; 21(4):319-24. PubMed ID: 15943576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.